Cargando…
Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
Objective: Magnesium (Mg(2+)) is cardioprotective and has been routinely used to supplement cardioplegic solutions during coronary artery bypass graft (CABG) surgery. However, there is no consensus about the Mg(2+) concentration that should be used. The aim of this study was to compare the effects o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162136/ https://www.ncbi.nlm.nih.gov/pubmed/21353585 http://dx.doi.org/10.1016/j.ejcts.2010.09.049 |
_version_ | 1782210786420064256 |
---|---|
author | Caputo, Massimo Santo, Kirkpatrick C. Angelini, Gianni D. Fino, Carlo Agostini, Marco Grossi, Claudio Suleiman, M.-Saadeh Reeves, Barnaby C. |
author_facet | Caputo, Massimo Santo, Kirkpatrick C. Angelini, Gianni D. Fino, Carlo Agostini, Marco Grossi, Claudio Suleiman, M.-Saadeh Reeves, Barnaby C. |
author_sort | Caputo, Massimo |
collection | PubMed |
description | Objective: Magnesium (Mg(2+)) is cardioprotective and has been routinely used to supplement cardioplegic solutions during coronary artery bypass graft (CABG) surgery. However, there is no consensus about the Mg(2+) concentration that should be used. The aim of this study was to compare the effects of intermittent antegrade warm-blood cardioplegia supplemented with either low- or high-concentration Mg(2+). Methods: This study was a randomised controlled trial carried out in two cardiac surgery centres, Bristol, UK and Cuneo, Italy. Patients undergoing isolated CABG with cardiopulmonary bypass were eligible. Patients were randomised to receive warm-blood cardioplegia supplemented with 5 or 16 mmol l(−1) Mg(2+). The primary outcome was postoperative atrial fibrillation. Secondary outcomes were serum biochemical markers (troponin I, Mg(2+), potassium, lactate and creatinine) and time-to-plegia arrest. Intra-operative and postoperative clinical outcomes were also recorded. Results: Data from two centres for 691 patients (342 low and 349 high Mg(2+)) were analysed. Baseline characteristics were similar for both groups. There was no significant difference in the frequency of postoperative atrial fibrillation in the high (32.8%) and low (32.0%) groups (risk ratio 1.03, 95% confidence interval, CI, 0.82–1.28). However, compared with the low group, troponin I release was 28% less (95% CI 55–94%, p = 0.02) in the high-Mg(2+) group. The 30-day mortality was 0.72% (n = 5); all deaths occurred in the high-Mg(2+) group but there was no significant difference between the groups (p = 0.06). Frequencies of other major complications were similar in the two groups. Conclusions: Warm-blood cardioplegia supplemented with 16 mmol l(−1) Mg(2+), compared with 5 mmol l(−1) Mg(2+), does not reduce the frequency of postoperative atrial fibrillation in patients undergoing CABG but may reduce cardiac injury. (This trial was registered as ISRCTN95530505.) |
format | Online Article Text |
id | pubmed-3162136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-31621362011-10-04 Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() Caputo, Massimo Santo, Kirkpatrick C. Angelini, Gianni D. Fino, Carlo Agostini, Marco Grossi, Claudio Suleiman, M.-Saadeh Reeves, Barnaby C. Eur J Cardiothorac Surg Article Objective: Magnesium (Mg(2+)) is cardioprotective and has been routinely used to supplement cardioplegic solutions during coronary artery bypass graft (CABG) surgery. However, there is no consensus about the Mg(2+) concentration that should be used. The aim of this study was to compare the effects of intermittent antegrade warm-blood cardioplegia supplemented with either low- or high-concentration Mg(2+). Methods: This study was a randomised controlled trial carried out in two cardiac surgery centres, Bristol, UK and Cuneo, Italy. Patients undergoing isolated CABG with cardiopulmonary bypass were eligible. Patients were randomised to receive warm-blood cardioplegia supplemented with 5 or 16 mmol l(−1) Mg(2+). The primary outcome was postoperative atrial fibrillation. Secondary outcomes were serum biochemical markers (troponin I, Mg(2+), potassium, lactate and creatinine) and time-to-plegia arrest. Intra-operative and postoperative clinical outcomes were also recorded. Results: Data from two centres for 691 patients (342 low and 349 high Mg(2+)) were analysed. Baseline characteristics were similar for both groups. There was no significant difference in the frequency of postoperative atrial fibrillation in the high (32.8%) and low (32.0%) groups (risk ratio 1.03, 95% confidence interval, CI, 0.82–1.28). However, compared with the low group, troponin I release was 28% less (95% CI 55–94%, p = 0.02) in the high-Mg(2+) group. The 30-day mortality was 0.72% (n = 5); all deaths occurred in the high-Mg(2+) group but there was no significant difference between the groups (p = 0.06). Frequencies of other major complications were similar in the two groups. Conclusions: Warm-blood cardioplegia supplemented with 16 mmol l(−1) Mg(2+), compared with 5 mmol l(−1) Mg(2+), does not reduce the frequency of postoperative atrial fibrillation in patients undergoing CABG but may reduce cardiac injury. (This trial was registered as ISRCTN95530505.) Oxford University Press 2011-09 /pmc/articles/PMC3162136/ /pubmed/21353585 http://dx.doi.org/10.1016/j.ejcts.2010.09.049 Text en © 2011 Elsevier B.V. This document may be redistributed and reused, subject to certain conditions (http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0) . |
spellingShingle | Article Caputo, Massimo Santo, Kirkpatrick C. Angelini, Gianni D. Fino, Carlo Agostini, Marco Grossi, Claudio Suleiman, M.-Saadeh Reeves, Barnaby C. Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
title | Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
title_full | Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
title_fullStr | Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
title_full_unstemmed | Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
title_short | Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
title_sort | warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162136/ https://www.ncbi.nlm.nih.gov/pubmed/21353585 http://dx.doi.org/10.1016/j.ejcts.2010.09.049 |
work_keys_str_mv | AT caputomassimo warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT santokirkpatrickc warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT angelinigiannid warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT finocarlo warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT agostinimarco warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT grossiclaudio warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT suleimanmsaadeh warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial AT reevesbarnabyc warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial |